Dexamethasone suppression test in patients with Parkinson's disease.
The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).
Kostić
V S
VS
Clinic for Neurology CCMF, Belgrade, Yugoslavia.
Covicković-Sternić
N
N
Beslać-Bumbasirević
L
L
Ocić
G
G
Pavlović
D
D
Nikolić
M
M
D003863:Depression / Q000175:diagnosis* / Q000209:etiology; D003907:Dexamethasone; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications*
D003907:Dexamethasone